HPV Vaccine-Related Research, Promotion and Coordination in the State of Georgia: A Systematic Review
- PMID: 30374822
- PMCID: PMC6414259
- DOI: 10.1007/s10900-018-0589-7
HPV Vaccine-Related Research, Promotion and Coordination in the State of Georgia: A Systematic Review
Abstract
Human papillomavirus (HPV) vaccine was first recommended for female adolescents in the United States in 2006, and for male adolescents in 2011. In 2016, national HPV vaccine coverage was 43.4%, and slightly higher in Georgia (45.6%). Little is known about sub-state-level variation in HPV vaccination or Georgia specific research conducted to improve HPV vaccine uptake. We aimed to describe current uptake of HPV vaccination and synthesize Georgia-specific research of HPV vaccine uptake. We reviewed existing published and grey literature for different development, implementation and best practices related to vaccine uptake in adolescents. Studies measuring HPV vaccine uptake in Georgia utilizing quantitative, qualitative, or mixed-methods approaches were included alongside state-level information from National Immunization Survey-Teen, Community Health Needs Assessments, Behavioral Risk Factor Surveillance and Georgia Adolescent Immunization Surveys. Key findings across these reports were summarized. Forty-two titles and abstracts were identified through electronic database search for literature published between 2006 and 2017. Of these, five were from database sources and 37 were from additional sources. The most often mentioned barriers of HPV vaccine uptake in Georgia include cultural norms, vaccination education and a misalignment of vaccine uptake goals between the state and regional hospital community needs assessments. Increasing knowledge and uptake of HPV vaccine in Georgia requires significant research and to understand the vast socioeconomic, cultural and geographic barriers preventing uptake among adolescents. Georgia-specific efforts have been limited, however ongoing collaborations spearheaded by the Georgia Cancer Control Coalition provide opportunities for state-level support of research to address these barriers.
Keywords: Georgia; HPV; HPV barriers; HPV vaccine coverage; Human papillomavirus.
Figures
References
-
- National Cancer Institute. (2016, 2016). HPV and Cancer. Retrieved from https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-ag...
-
- Cuzick J, Bergeron C, Knebel Doeberitz M, Gravitt P, Jeronimo J, Lorincz AT, & Szarewski A (2012). New Technologies and Procedures for Cervical Cancer Screening. Vaccine, 30(5), F107–F116. - PubMed
-
- Centers for Disease Control and Prevention. (2006, July 3, 2006). CDC’s advisory committee recommends human papillomavirus virus vaccination. Retrieved from https://www.cdc.gov/media/pressrel/r060629.htm - PubMed
-
- Centers for Disease Control and Prevention. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep, 60(50), 17051708. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
